Annual Long Term Debt
$478.70 M
+$2.59 M+0.54%
31 December 2023
Summary:
Coherus BioSciences annual long term debt is currently $478.70 million, with the most recent change of +$2.59 million (+0.54%) on 31 December 2023. During the last 3 years, it has risen by +$64.73 million (+15.64%). CHRS annual long term debt is now at all-time high.CHRS Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$268.25 M
-$15.00 K-0.01%
30 September 2024
Summary:
Coherus BioSciences quarterly long term debt is currently $268.25 million, with the most recent change of -$15.00 thousand (-0.01%) on 30 September 2024. Over the past year, it has dropped by -$205.96 million (-43.43%). CHRS quarterly long term debt is now -43.96% below its all-time high of $478.70 million, reached on 31 December 2023.CHRS Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CHRS Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +0.5% | -43.4% |
| 3 y3 years | +15.6% | -7.5% |
| 5 y5 years | +364.3% | +42.2% |
CHRS Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +15.6% | -44.0% | at low |
| 5 y | 5 years | at high | +364.3% | -44.0% | +42.2% |
| alltime | all time | at high | +377.5% | -44.0% | +170.1% |
Coherus BioSciences Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $268.25 M(-0.0%) |
| June 2024 | - | $268.26 M(-11.9%) |
| Mar 2024 | - | $304.35 M(-36.4%) |
| Dec 2023 | $478.70 M(+0.5%) | $478.70 M(+0.9%) |
| Sept 2023 | - | $474.21 M(-0.1%) |
| June 2023 | - | $474.81 M(-0.1%) |
| Mar 2023 | - | $475.42 M(-0.1%) |
| Dec 2022 | $476.10 M(+14.6%) | $476.10 M(-0.1%) |
| Sept 2022 | - | $476.62 M(+11.4%) |
| June 2022 | - | $427.78 M(+0.2%) |
| Mar 2022 | - | $426.97 M(+2.8%) |
| Dec 2021 | $415.53 M(+0.4%) | $415.53 M(+43.4%) |
| Sept 2021 | - | $289.87 M(-1.9%) |
| June 2021 | - | $295.52 M(-3.8%) |
| Mar 2021 | - | $307.28 M(-25.8%) |
| Dec 2020 | $413.97 M | $413.97 M(+0.1%) |
| Sept 2020 | - | $413.76 M(+0.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2020 | - | $413.37 M(+117.4%) |
| Mar 2020 | - | $190.15 M(+0.8%) |
| Dec 2019 | $188.64 M(+83.0%) | $188.64 M(+0.0%) |
| Sept 2019 | - | $188.60 M(+3.0%) |
| June 2019 | - | $183.15 M(-0.0%) |
| Mar 2019 | - | $183.16 M(+77.7%) |
| Dec 2018 | $103.09 M(+1.5%) | $103.09 M(+0.4%) |
| Sept 2018 | - | $102.71 M(+0.4%) |
| June 2018 | - | $102.33 M(+0.4%) |
| Mar 2018 | - | $101.97 M(+0.4%) |
| Dec 2017 | $101.61 M(+1.3%) | $101.61 M(+0.3%) |
| Sept 2017 | - | $101.26 M(+0.3%) |
| June 2017 | - | $100.92 M(+0.3%) |
| Mar 2017 | - | $100.58 M(+0.3%) |
| Dec 2016 | $100.26 M | $100.26 M(+0.3%) |
| Sept 2016 | - | $99.94 M(+0.3%) |
| June 2016 | - | $99.63 M(+0.3%) |
| Mar 2016 | - | $99.32 M |
FAQ
- What is Coherus BioSciences annual long term debt?
- What is the all time high annual long term debt for Coherus BioSciences?
- What is Coherus BioSciences annual long term debt year-on-year change?
- What is Coherus BioSciences quarterly long term debt?
- What is the all time high quarterly long term debt for Coherus BioSciences?
- What is Coherus BioSciences quarterly long term debt year-on-year change?
What is Coherus BioSciences annual long term debt?
The current annual long term debt of CHRS is $478.70 M
What is the all time high annual long term debt for Coherus BioSciences?
Coherus BioSciences all-time high annual long term debt is $478.70 M
What is Coherus BioSciences annual long term debt year-on-year change?
Over the past year, CHRS annual long term debt has changed by +$2.59 M (+0.54%)
What is Coherus BioSciences quarterly long term debt?
The current quarterly long term debt of CHRS is $268.25 M
What is the all time high quarterly long term debt for Coherus BioSciences?
Coherus BioSciences all-time high quarterly long term debt is $478.70 M
What is Coherus BioSciences quarterly long term debt year-on-year change?
Over the past year, CHRS quarterly long term debt has changed by -$205.96 M (-43.43%)